MOLLY MORAN: Open Payments
NPI 1336442540 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 26 payments from 9 companies in 2025. Trend: 2023 $743 · 2024 $561 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $274 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, REXULTI, FANAPT, SPRAVATO, Auvelity, INGREZZA, CAPLYTA, Jornay PM.
Industry payments across RI — which companies pay providers there.
